<html>
<head>PUBMED IDs for NXF5</head>
<body bgcolor='#C5F0F2'><h1>NXF5</h1><a href='https://pubmed.ncbi.nlm.nih.gov/11566096/'>NXF5, a novel member of the nuclear RNA export factor family, is lost in a male patient with a syndromic form of mental retardation.</a> September 22  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/12784308/'>Inv(X)(p21.1;q22.1) in a man with mental retardation, short stature, general muscle wasting, and facial dysmorphism: clinical study and mutation analysis of the NXF5 gene.</a> June 5  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/17546640/'>Detection of genomic copy number changes in patients with idiopathic mental retardation by high-resolution X-array-CGH: important role for increased gene dosage of XLMR genes.</a> June 5  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/20096387/'>Familial 1.1 Mb deletion in chromosome Xq22.1 associated with mental retardation and behavioural disorders in female patients.</a> July 16  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21685710/'>Disease-dependent differently methylated regions (D-DMRs) of DNA are enriched on the X chromosome in uterine leiomyoma.</a> March 6  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/23675524/'>Generation and characterization of an Nxf7 knockout mouse to study NXF5 deficiency in a patient with intellectual disability.</a> December 16  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23675521/'>Retinal pigmented epithelial cells cytotoxicity and apoptosis through activation of the mitochondrial intrinsic pathway: role of indocyanine green, brilliant blue and implications for chromovitrectomy.</a> December 18  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23686279/'>Unique X-linked familial FSGS with co-segregating heart block disorder is associated with a mutation in the NXF5 gene.</a> March 19  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23871722/'>XLID-causing mutations and associated genes challenged in light of data from large-scale human exome sequencing.</a> December 18  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23871720/'>Cathelicidin, kallikrein 5, and serine protease activityÂ is inhibited during treatment of rosacea with azelaic acid 15% gel.</a> December 16  2013<br></body></html>
